Product Description
Overall, the global EUS needle market was valued at nearly $374 million in 2025. This is expected to increase over the forecast period at a CAGR of 3.9% to reach over $490 million.
This full report suite includes the global market for endoscopic ultrasound (EUS) needles. The market is further segmented by type into fine-needle aspiration (FNA) and fine-needle biopsy (FNB).
Data Types Included
- Unit Sales, Average Selling Prices, Market Size & Growth Trends
- Procedure Numbers
- Market Drivers & Limiters
- Market Forecasts Until 2032, and Historical Data to 2022
- Recent Mergers & Acquisitions
- Company Profiles and Product Portfolios
- Leading Competitors
Global EUS Needle Market Trends
The introduction of newer diagnostic approaches, particularly EUS-guided interventions, is expected to strengthen the ability to identify abnormalities and disease states within the gastrointestinal tract. At the same time, innovations in imaging, such as improved visualization technologies, are enhancing procedural precision and contributing to more reliable diagnostic outcomes.
Global EUS Needle Market Share Insights
- Boston Scientific in 2025 held the leading position in the EUS market. The company has established a strong presence in the EUS needle segment with its Acquire™ fine-needle biopsy (FNB) devices and Expect™ fine-needle aspiration (FNA) product line, securing a significant share of the market.
- Cook Medical ranked as the second-largest competitor in the overall EUS needle device market in 2025. The company maintains a strong position through its EchoTip® Ultra Endoscopic Ultrasound Needle and also participates in the reusable segment of the market, broadening its competitive presence.
- Medtronic has secured a notable share of the EUS needle device market, supported in part by its portfolio of reusable products in 2025. The company’s presence in the segment is anchored by its SharkCore™ fine-needle biopsy (FNB) system and Beacon™ fine-needle aspiration (FNA) system, which contribute meaningfully to its sales performance
Global EUS Needle Market Segmentation Summary
- Fine Needle Aspiration Market
- Fine Needle Biopsy Market
Research Scope Summary
| Report Attribute | Details |
|---|---|
| Regions | North America (Canada, United States) Latin America (Argentina, Bolivia, Brazil, Chile, Colombia, Costa Rica, Dominican Republic, Ecuador, Guatemala, Mexico, Panama, Paraguay, Peru, Puerto Rico, Uruguay, Venezuela) Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, United Kingdom) Central & Eastern Europe (Azerbaijan, Baltic States, Belarus, Bulgaria, Croatia, Czech Republic, Georgia, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Serbia, Slovakia, Slovenia, Turkey, Ukraine) Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates) Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Kyrgyzstan, Macao, Malaysia, Mongolia, Myanmar, New Zealand, Pakistan, Philippines, Singapore, South Korea, Sri Lanka, Taiwan, Thailand, Uzbekistan, Vietnam) Africa (Algeria, Egypt, Ethiopia, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda |
| Base Year | 2025 |
| Forecast | 2026-2032 |
| Historical Data | 2022-2024 |
| Quantitative Coverage | Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices. |
| Qualitative Coverage | Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews. |
| Data Sources | Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database. |
CONTACT US FOR ADDITIONAL INFORMATION
For full segmentation and any questions regarding research coverage, please contact us for a complimentary demo of the full report.
